Acción LA JOLLA PHARM
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas LA JOLLA PHARM Other OTC

Acciones

Precio de cierre Other OTC
Otros sitios de cotización
- USD - Gráfico intradía de LA JOLLA PHARM
2022 La Jolla Pharmaceutical anuncia cambios en la dirección CI
2022 Innoviva, Inc. (NasdaqGS:INVA) completó la adquisición de La Jolla Pharmaceutical Company (NasdaqCM:LJPC). CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
La Jolla Pharmaceutical Announces Management Changes
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index
Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.
La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
Equity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPC
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership (Form 4)
SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción LJPC
  4. Acción
  5. Noticias LA JOLLA PHARM
  6. Otros idiomas